Related Experiment Video

Updated: Aug 7, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Rapid identification of small interfering RNA that can effectively inhibit the replication of multiple influenza B

Yongzhen Gao1, Lilian Sun, Jie Dong

  • 1State Key Laboratory for Molecular Virology and Genetic Engineering, Beijing 100176, China.

Antiviral Therapy
|July 22, 2006
PubMed

Insights

Small interfering RNA (siRNA) effectively inhibits influenza B virus replication in cell cultures and chicken embryos. This RNA interference approach shows promise for managing influenza B infections, offering broad protection against multiple strains.

Area of Science:

  • Virology
  • Molecular Biology
  • RNA Interference

Background:

  • Influenza B virus causes significant human illness and death.
  • Current vaccines and antiviral drugs offer limited protection against influenza B.
  • Novel therapeutic strategies are needed to combat influenza B virus infections.

Purpose of the Study:

  • To evaluate the efficacy of small interfering RNA (siRNA) in inhibiting influenza B virus replication.
  • To assess the potential of RNA interference as a therapeutic strategy against influenza B.

Main Methods:

  • Chemically synthesized and plasmid-encoded siRNAs targeting conserved influenza B virus regions were designed.
  • siRNA efficacy was tested in cultured cells and chicken embryos.
  • Viral replication was measured to determine the antiviral effect.

Main Results:

  • Several siRNAs effectively blocked influenza B virus replication.
  • The tested siRNAs demonstrated broad protection against diverse influenza B virus strains.
  • The antiviral potency of siRNA was comparable to the established drug ribavirin.

Conclusions:

  • RNA interference using siRNA is a potent strategy for inhibiting influenza B virus replication.
  • siRNA offers broad-spectrum activity against multiple influenza B strains.
  • Further research into siRNA-based therapies for influenza B virus is warranted.

More Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

High-throughput Detection Method for Influenza Virus10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...